⌘K

Home/Filings/4/0000950170-24-113297

4//SEC Filing

Bellete Ambaw 4

Accession 0000950170-24-113297

CIK 0001991792other

View on SEC.gov Company Profile

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 5:00 PM ET

Size

5.4 KB

Accession

0000950170-24-113297

Insider Transaction Report

Form 4

Period: 2024-10-04

CG Oncology, Inc.CGON

President and COO

Transactions

Award
Stock Option (Right to Buy)
2024-10-04+175,500→ 175,500 total
Exercise: $36.63Exp: 2034-10-03→ Common Stock (175,500 underlying)

Footnotes (1)

[F1]1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

CG Oncology, Inc.

CIK 0001991792

Entity typeother

Related Parties

1

filerCIK 0002007090

Filing Metadata

Form type: 4
Filed: Oct 6, 8:00 PM ET
Accepted: Oct 7, 5:00 PM ET
Size: 5.4 KB

View on SEC.gov